Efalizumab and asthma 
Efalizumab and asthma Patient Reports February 11, 2012
Efalizumab Side Effects Report #5050817-8
Efalizumab side effect was reported by a Physician from SWITZERLAND on June 29, 2006. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, arthritis
, asthenia, asthma , basophil count increased, blood potassium increased, condition aggravated, eosinophil count increased, hypertension. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #5122588-8
Efalizumab side effect was reported by a Consumer or non-health professional from BRAZIL on Sept 22, 2006. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthritis
, asthenia, asthma , basophil count increased, blood potassium increased, condition aggravated, eosinophil count increased, hypertension, hypochromic anaemia. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #4836678-8
Efalizumab side effect was reported by a Health Professional from SWITZERLAND on Nov 03, 2005. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, asthenia, asthma
, blood potassium increased, condition aggravated, eosinophil count increased, hypochromic anaemia, myalgia, oedema peripheral. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #4852003-0
Efalizumab side effect was reported by a Consumer or non-health professional from BRAZIL on Nov 23, 2005. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, arthralgia, asthenia, asthma
, basophil count increased, blood potassium increased, condition aggravated, eosinophil count increased, hypertension. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #4917796-2
Efalizumab side effect was reported by a Physician from BRAZIL on Jan 30, 2006. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, arthralgia, arthritis
, asthenia, asthma , blood potassium increased, condition aggravated, hypertension, lymphadenopathy. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #4998726-4
Efalizumab side effect was reported by a Physician from BRAZIL on May 05, 2006. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthritis
, asthenia, asthma , basophil count increased, blood potassium increased, condition aggravated, eosinophil count increased, hypertension, hypochromic anaemia. Efalizumab dosage: 0.142 MG/KG, 1/WEEK. Patient was hospitalized. Patient recovered.